🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II MATCH treatment trial tests how well BVD-523FB (ulixertinib) ...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2019-07-24
Trial ID
NCT06400225
This study is being performed to assess the safety, tolerability, and preli...
Status
Completed
Location
UCLA Medical Center
Start Date
2014-11
Trial ID
NCT02296242
Treatments Being Tested
Open-label dose escalation of Ulixertinib combined with fixed dose of hydro...
Status
Completed
Location
Huntsman Cancer Institute
Start Date
2020-03-17
Trial ID
NCT04145297
Treatments Being Tested
This phase II Pediatric MATCH trial studies how well ulixertinib works in t...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-11-14
Trial ID
NCT03698994
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This open-label, multi-center Phase 1/2 study will assess the safety, pharm...
Status
Completed
Location
UCLA Med-Hematology & Oncology
Start Date
2013-03
Trial ID
NCT01781429
Treatments Being Tested
This BVD-523-ABC study builds on the safety and clinical activity experienc...
Status
Terminated
Location
Mayo Clinic
Start Date
2021-01-07
Trial ID
NCT04488003
Treatments Being Tested
The objective of this expanded access program is to provide ulixertinib (BV...
Status
Available
Location
Infirmary Cancer Care
Start Date
TBD
Trial ID
NCT04566393
Treatments Being Tested
The researchers are doing this study to find out whether the combination of...
Status
Recruiting
Location
Massachusetts General Hospital (Data Collection Only)
Start Date
2025-01-07
Trial ID
NCT06773195
Treatments Being Tested
To learn if the study drug, ulixertinib, can cross over the blood-brain bar...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-04-20
Trial ID
NCT05804227
Treatments Being Tested